Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.

[1]  S. Spector,et al.  Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group. , 1998, Chest.

[2]  A. Grahnén,et al.  A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler , 1997, European Journal of Clinical Pharmacology.

[3]  A. Ullman,et al.  Assessment of the relative systemic potency of inhaled fluticasone and budesonide. , 1996, The European respiratory journal.

[4]  M. Zureik,et al.  Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. , 1994, The European respiratory journal.

[5]  R. N. Brogden,et al.  Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. , 1992, Drugs.

[6]  R. Dockhorn,et al.  A comparative study of the effects of intranasal triamcinolone acetonide aerosol (ITAA) and prednisone on adrenocortical function. , 1992, The Journal of allergy and clinical immunology.

[7]  J. Baskerville,et al.  Effects of dose and dosing schedule of inhaled budesonide on bone turnover. , 1991, The Journal of allergy and clinical immunology.

[8]  T. Haahtela,et al.  Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. , 1991, The New England journal of medicine.

[9]  C. Reed.  Aerosol steroids as primary treatment of mild asthma. , 1991, The New England journal of medicine.

[10]  U. Pipkorn,et al.  Glucocorticoids: experimental approaches , 1991 .

[11]  J. Baskerville,et al.  A study of the mechanism of the antiasthmatic action of inhaled budesonide. , 1990, The Journal of allergy and clinical immunology.

[12]  J. Baskerville,et al.  Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. , 1989, The Journal of allergy and clinical immunology.

[13]  P. Ebden,et al.  Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma. , 1986, Thorax.

[14]  B. Weeke,et al.  High-dose inhaled budesonide in treatment of severe steroid-dependent asthma. , 1986, European journal of respiratory diseases.

[15]  D. Streeten,et al.  Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man. , 1984, Endocrine reviews.

[16]  J. Gustafsson,et al.  Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids. , 1984, Molecular pharmacology.

[17]  A. Ryrfeldt,et al.  Metabolic pathways of the topical glucocorticoid budesonide in man. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[18]  S. Johansson,et al.  Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide. , 1983, British journal of clinical pharmacology.

[19]  E. Hansson,et al.  Budesonide: a new corticosteroid in bronchial asthma. , 1980, European journal of respiratory diseases.

[20]  J. Thijssen,et al.  A quantitative assay of cortisol in human plasma by high performance liquid chromatography using a selective chemically bonded stationary phase. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[21]  M. Kaliner,et al.  On Asthma: Its Pathology and Treatment , 1869, Annals of Internal Medicine.